이상반응 보고
| VAERS ID | 955676 |
|---|---|
| 성별 | 여성 |
| 나이 | |
| 주 코드 | FR |
| 제약회사 | PFIZER\BIONTECH |
| 로트 번호 | |
| 예방접종 횟수 | |
| 접종일 | |
| 발병일 | 2021-01-06 |
| 상태 | 후유증 |
증상
- 관절통(Arthralgia)
- 두통(Headache)
- 현기증(Dizziness)
- 오한(Chills)
- 메스꺼움(Nausea)
- 예방 접종 부위 통증(Vaccination site pain)
- 과수면(Hypersomnia)
이환 중 질병
지병
Medical History/Concurrent Conditions: Bladder disorder; Hypertension
기타 의료
이전 예방접종
알레르기
임상 검사
증상 상세
lightheadedness; dull headache; Joint pain; Chills; Nausea; slept a lot; Pain at injection site; This is a spontaneous report from a contactable healthcare professional received by Pfizer from the Medicines and Healthcare products Regulatory Agency (MHRA).
The regulatory authority report number is GB-MHRA-WEBCOVID-20210108085503, Safety Report Unique Identifier GB-MHRA-ADR 24571562.
A 58-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, unknown lot number and expiration), via an unspecified route of administration, on an unspecified date, at single dose, for COVID-19 immunisation.
Medical history included weak bladder and hypertension.
Concomitant medications included amlodipine for hypertension, influenza vaccine (INFLUENZA VIRUS) on 23Nov2020 for influenza immunization, and tolterodine.
On 06Jan2021, the patient experienced pain at injection site.
The patient also experienced lightheadedness on unspecified date which developed into a dull headache on 06Jan2021.
Within a couple of hours on 06Jan2021, joint pain started; chills occurred later in the evening.
Patient slept a lot and nausea was felt on the same day.
Paracetamol was taken.
Patient has not had symptoms associated with COVID-19.
Patient has not been tested/or has had an inconclusive test for COVID-19.
Patient is not enrolled in clinical trial.
The patient recovered from the events joint pain, chills, nausea, slept a lot, and pain at injection site on 08Jan2021; recovering from the event dull headache; while unknown outcome for lightheadedness.
The events were assessed as serious (disability).
No follow-up attempts are possible; information about lot/batch number cannot be obtained.